PharmiWeb.com - Global Pharma News & Resources
22-Aug-2025

Global Prescription Lens Market to Grow at 5% CAGR, Driven by Eye Health & Tech Advancements 2030

The global prescription lens market is expected to grow at a CAGR of ~5% during the forecast period. Rising prevalence of vision disorders due to increasing screen time, growing awareness of eye health and routine eye check-ups, advancements in lens technology, and expansion of optical retail chains and online eyewear platforms are some of the key driving factors supporting market growth. However, the high cost of prescription lenses and limited access to eye care services remain major restraints impacting the growth of the prescription lens market. 

Prescription lenses refer to optical lenses designed to correct vision problems by adjusting the refraction of light to ensure it properly focuses on the retina. These lenses are prescribed by eye care professionals (Ophthalmologists and Optometrists) after a detailed eye test and are used to treat refractive errors. Prescription lenses play an important role in restoring clear vision and improving visual comfort for individuals with various vision problems. Some common types of prescription lenses include Single Vision Lenses, Bifocal Lenses, Progressive Lenses, High-Index Lenses, Photochromic Lenses and Blue-Light Filtering Lenses. Overall, prescription lenses are essential tools for preventing further eye strain and long-term complications by providing targeted visual correction.

Download a free sample report for in-depth market insights
https://meditechinsights.com/prescription-lens-market/request-sample/

Rising vision disorders fuel the demand for prescription lenses

A major factor driving demand for prescription lenses is the rising number of people with vision problems. Conditions such as myopia (nearsightedness), hyperopia/hypermetropia (farsightedness), and astigmatism are becoming more common globally. These refractive errors occur due to the prolonged use of digital devices like smartphones and computers, along with sedentary indoor lifestyles. The surge in screen time across all age groups has led to digital eye strain and the early onset of vision issues among young adults and children. For instance, an article published by the World Health Organization reported that 2.2 billion people globally experience near or distant vision impairment, with at least 1 billion cases being preventable or untreated. Refractive errors and cataracts remain the leading causes, highlighting a significant need for access to eye care and diagnostics.

With increasing awareness about eye health and preventive care, more people are opting for regular eye checkups, leading to a steady rise in the number of people being prescribed with corrective lenses. Organizations like Sightsavers are also active in many countries to help detect and treat refractive errors, especially in underserved communities. Also, in April 2025, the International Agency for the Prevention of Blindness (IAPB), in collaboration with 13 global health and education groups, issued a policy alert warning of a ‘growing crisis in children’s eye health' across Europe, linked to increased screen time and less outdoor activity. The coalition projected that up to 50% of European school dropouts could be myopic by 2035. As a result, rising cases of vision disorders are driving demand for prescription lenses, including customized and specialized types of lenses. 

Prescription lenses with blue light protection gain traction

One of the most significant trends seen in the prescription lens market is the growing preference for blue light filtering and digital eye strain protection. As digital devices have become an indispensable part of our daily lives, including work, education, and entertainment, people are spending more time in front of screens. The prolonged exposure to screens that emit blue light is leading to the increased number of issues like dry eyes, headaches, and blurred vision.

Blue light, when absorbed in excess, results in visual fatigue and may disrupt the circadian rhythms by suppressing melatonin production, affecting sleep and long-term eye health. To address this growing concern, lens manufacturers are now offering prescription lenses with integrated blue light filters. These lenses filter out a significant amount of harmful blue light emitted by digital screens. Some lenses also come with anti-reflective coatings and UV protection, which further enhances the visual comfort and reduces glare. This innovation has gained popularity among working professionals, students, and children, who spend more time on digital devices. Especially, post-pandemic lifestyle changes like remote work and online learning have increased screen time for all age groups. Additionally, people are now opting for prescription lenses that combine both vision correction and blue light protection in a single product. For Instance,

  • In January 2025, ZEISS Vision Care launched four new prescription sun lens tints paired with DuraVision Gold UV coatings, blending style with strong UV and glare protection
  • In March 2024, Transitions Optical introduced its GEN S light-adaptive lenses, which block 100% of UVA and UVB rays, filter up to 32% of blue-violet light indoors and up to 85% when darkened, providing fast-switching photochromic performance

Competitive Landscape Analysis

The global prescription lens market comprises of several well-established and emerging players, including EssilorLuxottica; Carl Zeiss AG; Rodenstock GmbH; Seiko Optical Products Co. Ltd.; Shamir Optical Industry Ltd.; Vision Ease (HOYA Corporation); Corning Incorporated; Tokai Optical Co., Ltd.; Prive Revaux and Vision Rx Lab; among others. Key strategies adopted by these players include the development of advanced lens technologies (such as blue light filtering and photochromic lenses), mergers and acquisitions, and investment in R&D to enhance vision correction solutions and meet growing global demand.

Unlock key data with a sample report for competitive analysis:
https://meditechinsights.com/prescription-lens-market/request-sample/

Global Prescription Lens Market Segmentation

This report by Medi-Tech Insights provides the size of the global prescription lens market at the regional- and country-level from 2023 to 2030. The report further segments the market based on lens type, lens coating, and application.

Market Size & Forecast (2023-2030), By Lens Type, USD Million

  •  
    • Single Vision
    • Convex
    • Concave
    • Cylindrical
    • Bifocal
    • Trifocal
    • Progressive
    • Active / Sports Lenses
    • Others

Market Size & Forecast (2023-2030), By Lens Coating, USD Million

  •  
    • Anti-reflective
    • Scratch-resistant coating
    • Anti-fog coating
    • Ultraviolet treatment

Market Size & Forecast (2023-2030), By Application, USD Million

  •  
    • Myopia
    • Hyperopia/ Hypermetropia
    • Astigmatism
    • Presbyopia

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com 

Global Prescription Lens Market to Grow at 5% CAGR, Driven by Eye Health & Tech Advancements 2030

Editor Details

Related Links

Last Updated: 22-Aug-2025